Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L2NG
|
|||
| Drug Name |
4-aryl quinol derivative 1
|
|||
| Synonyms |
PMID27977313-Compound-20
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
CANCER RESEARCH TECHNOLOGY LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H10O2S
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C=C(S2)C3(C=CC(=O)C=C3)O
|
|||
| InChI |
1S/C14H10O2S/c15-11-5-7-14(16,8-6-11)13-9-10-3-1-2-4-12(10)17-13/h1-9,16H
|
|||
| InChIKey |
TXEIZQHZDIXJLD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytoplasmic thioredoxin reductase (TXNRD1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Cytoplasmic thioredoxin reductase (TXNRD1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.